• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中肛门鳞癌的系统评价。

A systematic review of anal squamous cell carcinoma in inflammatory bowel disease.

机构信息

Division of Surgery and Cancer, Chelsea and Westminster Campus, Imperial College London, UK; Department of Colorectal Surgery, The Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK.

出版信息

Surg Oncol. 2013 Dec;22(4):230-7. doi: 10.1016/j.suronc.2013.08.002. Epub 2013 Aug 26.

DOI:10.1016/j.suronc.2013.08.002
PMID:24050823
Abstract

AIM

The aim of this systematic review was to determine the incidence, aetiology and clinical characteristics of anal squamous cell carcinomas (SCC) presenting in patients with inflammatory bowel disease.

METHOD

A systematic review of the literature was undertaken using Medline, Embase, Cochrane and Web of Science.

RESULTS

A total of 33 cases of anal SCC were described, 7 in ulcerative colitis (UC) and 26 in Crohn's disease (CD). The annual incidence of anal SCCs was 0.9/100,000 and 2.0/100,000 in patients with UC and CD respectively. The gender ratio in CD was 3M:17F with a median age of 42 years, the main presenting symptom was anal pain and 85% of CD cases had peri-anal disease. No studies described anal intra-epithelial neoplasia. The human papilloma virus was found to be positive in 2 out of 5 (40%) cases. The majority of patients (73%) with CD received radical surgery as their first line treatment. The cumulative overall and disease free survival in CD was 37 per cent at five years.

CONCLUSION

The findings of this review when contrasted with the data from cancer registries suggests that there is a higher incidence of anal SCC, an earlier age of presentation and poorer outcomes in patients with Crohn's disease compared to the general population implying a more aggressive neoplastic process. This review supports the hypothesis that peri-anal disease plays a contributing role in anal SCCs and as such targeted surveillance in patients with longstanding peri-anal disease should be considered.

摘要

目的

本系统评价的目的是确定患有炎症性肠病的患者中出现的肛门鳞状细胞癌(SCC)的发病率、病因和临床特征。

方法

使用 Medline、Embase、Cochrane 和 Web of Science 进行文献系统评价。

结果

共描述了 33 例肛门 SCC,7 例溃疡性结肠炎(UC)和 26 例克罗恩病(CD)。UC 和 CD 患者肛门 SCC 的年发病率分别为 0.9/100,000 和 2.0/100,000。CD 的性别比例为 3M:17F,中位年龄为 42 岁,主要症状为肛门疼痛,85%的 CD 病例有肛周疾病。没有研究描述肛门上皮内瘤变。发现 5 例中的 2 例(40%)人乳头瘤病毒阳性。大多数(73%)CD 患者接受根治性手术作为一线治疗。CD 的 5 年总生存率和无病生存率为 37%。

结论

与癌症登记数据相比,本研究结果表明,与普通人群相比,克罗恩病患者的肛门 SCC 发病率更高,发病年龄更早,预后更差,这意味着更具侵袭性的肿瘤过程。本综述支持肛周疾病在肛门 SCC 中起作用的假设,因此应考虑对长期肛周疾病患者进行靶向监测。

相似文献

1
A systematic review of anal squamous cell carcinoma in inflammatory bowel disease.炎症性肠病中肛门鳞癌的系统评价。
Surg Oncol. 2013 Dec;22(4):230-7. doi: 10.1016/j.suronc.2013.08.002. Epub 2013 Aug 26.
2
Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.干预措施用于克罗恩病和炎症性肠病的腹痛管理。
Cochrane Database Syst Rev. 2021 Nov 29;11(11):CD013531. doi: 10.1002/14651858.CD013531.pub2.
3
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD000279. doi: 10.1002/14651858.CD000279.pub3.
4
Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.检测炎症性肠病患者结肠癌和/或发育异常的策略。
Cochrane Database Syst Rev. 2004(2):CD000279. doi: 10.1002/14651858.CD000279.pub2.
5
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
6
Strategies for detecting colon cancer in patients with inflammatory bowel disease.炎症性肠病患者结肠癌的检测策略。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD000279. doi: 10.1002/14651858.CD000279.pub4.
7
The impact of biological interventions for ulcerative colitis on health-related quality of life.溃疡性结肠炎生物干预措施对健康相关生活质量的影响。
Cochrane Database Syst Rev. 2015 Sep 22;2015(9):CD008655. doi: 10.1002/14651858.CD008655.pub3.
8
St Andrews Referral Delay in Skin Cancer (StARDISC): a study of keratinocyte skin cancer time to treatment, growth, invasiveness, British Association of Dermatologists risk factors and excision adequacy.圣安德鲁斯皮肤癌转诊延迟研究(StARDISC):一项关于角质形成细胞皮肤癌治疗时间、生长、侵袭性、英国皮肤科医师协会危险因素及切除充分性的研究。
Br J Dermatol. 2025 Jun 20;193(1):157-166. doi: 10.1093/bjd/ljaf097.
9
Aminosalicylates for induction of remission or response in Crohn's disease.用于诱导克罗恩病缓解或反应的氨基水杨酸盐。
Cochrane Database Syst Rev. 2016 Jul 3;7(7):CD008870. doi: 10.1002/14651858.CD008870.pub2.
10
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.硫唑嘌呤或6-巯基嘌呤用于维持克罗恩病的缓解状态。
Cochrane Database Syst Rev. 2015 Oct 30;2015(10):CD000067. doi: 10.1002/14651858.CD000067.pub3.

引用本文的文献

1
Radiation Therapy for Abdominal or Pelvic Cancer Treatment in Patients with Inflammatory Bowel Disease: A Systematic Review.炎症性肠病患者腹部或盆腔癌的放射治疗:一项系统评价
Dig Dis Sci. 2025 Jun 17. doi: 10.1007/s10620-025-09128-2.
2
Nonfistulizing Perianal Crohn's Disease.非瘘管性肛周克罗恩病
Clin Colon Rectal Surg. 2024 Apr 19;38(2):141-147. doi: 10.1055/s-0044-1786198. eCollection 2025 Mar.
3
Rare Finding of Rectal Squamous Metaplasia in Inflammatory Bowel Disease.炎症性肠病中罕见的直肠鳞状化生发现
ACG Case Rep J. 2025 Jan 17;12(1):e01598. doi: 10.14309/crj.0000000000001598. eCollection 2025 Jan.
4
Establishment of a surveillance program for anal cancer in Crohn's disease.建立克罗恩病肛门癌监测项目。
World J Gastroenterol. 2024 Dec 7;30(45):4844-4849. doi: 10.3748/wjg.v30.i45.4844.
5
Navigating the complexities of perianal Crohn's disease: Diagnostic strategies, treatment approaches, and future perspectives.肛周克罗恩病的复杂性:诊断策略、治疗方法及未来展望。
World J Gastroenterol. 2024 Nov 28;30(44):4745-4753. doi: 10.3748/wjg.v30.i44.4745.
6
Unexpected Foreign Body-Induced Small Bowel adenocarcinoma: A Case Report.意外的异物诱发小肠腺癌:一例报告
J Inflamm Res. 2024 Sep 24;17:6723-6728. doi: 10.2147/JIR.S477855. eCollection 2024.
7
Inflammatory Bowel Disease Treatment in Cancer Patients-A Comprehensive Review.癌症患者的炎症性肠病治疗——全面综述
Cancers (Basel). 2023 Jun 9;15(12):3130. doi: 10.3390/cancers15123130.
8
Anal Adenocarcinoma Arising From a Fistula-in-Ano: A Case Report.起源于肛瘘的肛管腺癌:一例报告
Cureus. 2022 Nov 10;14(11):e31339. doi: 10.7759/cureus.31339. eCollection 2022 Nov.
9
Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review.炎症性肠病相关恶性肿瘤及放疗对肠道影响的考量:一项范围综述
J Gastrointest Oncol. 2022 Oct;13(5):2565-2582. doi: 10.21037/jgo-22-138.
10
The Role of Inflammation in Anal Cancer.炎症在肛管癌中的作用。
Diseases. 2022 May 6;10(2):27. doi: 10.3390/diseases10020027.